Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors...
Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.
New diagnostic guidelines for suspected epilepsy focus on ruling out seizures and classifying focal or...
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a...
New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.
Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with...
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...